Answer
Stevens–Johnson syndrome (rare) and toxic epidermal necrolysis (frequency not known) have been reported in association with Tagrisso (osimertinib mesylate) treatment.
Sources for this answer
- Tagrisso 40 mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 32Document updated
Sources checked